# TELIX PHARMACEUTICALS LIMITED

> Australian public company

**Wikidata**: [Q109627134](https://www.wikidata.org/wiki/Q109627134)  
**Source**: https://4ort.xyz/entity/telix-pharmaceuticals-limited

## Summary
TELIX PHARMACEUTICALS LIMITED is an Australian public company, officially known by its full name, that offers its securities for sale to the general public. It is listed on the Australian Securities Exchange (ASX) under the ticker symbol TLX. As of November 18, 2021, its market capitalization was over 1.8 billion Australian dollars.

## Key Facts
*   **Official Name:** TELIX PHARMACEUTICALS LIMITED
*   **Type:** Australian public company
*   **Website:** https://telixpharma.com/
*   **ISIN:** AU000000TLX2
*   **Stock Exchange Listing:** Australian Securities Exchange (ASX)
*   **ASX Ticker Symbol:** TLX
*   **ASX Listing Date:** November 15, 2017
*   **Market Capitalization:** 1,875,779,735 Australian dollars (as of November 18, 2021)
*   **Source for public company status, official name, stock exchange, market cap:** Australian Securities Exchange directory (referenced 2021-11-18)

## FAQs
**What is TELIX PHARMACEUTICALS LIMITED?**
TELIX PHARMACEUTICALS LIMITED is an Australian public company that operates by offering its securities to the general public. This structure allows it to raise capital from a broad base of investors.

**What is the official name and website of the company?**
The official name of the entity is TELIX PHARMACEUTICALS LIMITED. Its official website can be found at https://telixpharma.com/.

**Where is TELIX PHARMACEUTICALS LIMITED publicly traded?**
The company is publicly traded on the Australian Securities Exchange (ASX) under the ticker symbol TLX. It commenced trading on the ASX on November 15, 2017.

**What is its market capitalization?**
As of November 18, 2021, TELIX PHARMACEUTICALS LIMITED had a market capitalization of 1,875,779,735 Australian dollars.

**What is the ISIN for TELIX PHARMACEUTICALS LIMITED?**
The International Securities Identification Number (ISIN) for TELIX PHARMACEUTICALS LIMITED is AU000000TLX2.

## Why It Matters
As an Australian public company, TELIX PHARMACEUTICALS LIMITED plays a role in the nation's capital markets by allowing public investment and contributing to economic activity. Its status as a publicly traded entity enables it to raise capital from a wide pool of investors, which is crucial for business expansion and innovation. This structure also provides liquidity for investors, allowing them to easily buy and sell ownership stakes, thereby facilitating wealth creation and savings for individuals.

## Notable For
*   Being an Australian public company listed on the Australian Securities Exchange (ASX).
*   Its significant market capitalization, recorded at 1,875,779,735 Australian dollars as of November 18, 2021.
*   Its listing on a major stock exchange, which requires adherence to strict regulatory disclosure and reporting standards, promoting transparency for investors.

## Body

### Overview and Corporate Identity
TELIX PHARMACEUTICALS LIMITED is an Australian public company, officially known by its full name. Its online presence is maintained through its official website, https://telixpharma.com/. The company is identified by the International Securities Identification Number (ISIN) AU000000TLX2.

### Public Listing and Stock Exchange Information
TELIX PHARMACEUTICALS LIMITED is listed on the Australian Securities Exchange (ASX), which is a primary market for securities trading in Australia. The company trades under the ticker symbol TLX. Its shares began trading on the ASX on November 15, 2017, marking its entry into the public market. This listing allows the company to offer its securities for sale to the general public, enabling it to raise capital from a broad base of investors.

### Financial Standing
As of November 18, 2021, TELIX PHARMACEUTICALS LIMITED held a market capitalization of 1,875,779,735 Australian dollars. This valuation reflects the total market value of its outstanding shares at that specific point in time.

### Nature as a Public Company
As a public company, TELIX PHARMACEUTICALS LIMITED is characterized by its ability to offer its securities, such as stock or bonds, for sale to the general public, typically through a stock exchange like the ASX. This distinguishes it from private companies, which raise funds from a smaller, closed group of investors. The ownership of TELIX PHARMACEUTICALS LIMITED is distributed among its general public shareholders. This structure is a fundamental pillar of modern capitalism, facilitating large-scale capital formation for business expansion and innovation. Public companies are required to adhere to strict regulatory disclosure and reporting standards, which promotes transparency for investors and the broader market.

## References

1. [Source](https://www2.asx.com.au/markets/trade-our-cash-market/directory)